NRX Pharmaceuticals (NRXP) Enterprise Value Growth (3y) (2020 - 2026)
NRX Pharmaceuticals (NRXP) Enterprise Value Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | NRX Pharmaceuticals | 117.34 Mn | 110.64 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.96% |
| Dec 31, 2025 | 27.01% |
| Sep 30, 2025 | 26.71% |
| Jun 30, 2025 | 50.93% |
| Mar 31, 2025 | 48.47% |
| Dec 31, 2024 | 62.61% |
| Sep 30, 2024 | 65.48% |
| Jun 30, 2024 | 47.84% |
| Mar 31, 2024 | 53.68% |
| Dec 31, 2023 | -35.22% |
| Sep 30, 2023 | -90.50% |
| Jun 30, 2023 | -146.78% |
| Mar 31, 2023 | -489.01% |
| Dec 31, 2022 | -183.79% |
| Sep 30, 2022 | -354.57% |
| Jun 30, 2022 | -2,501.66% |
| Mar 31, 2022 | -2,706.80% |
| Dec 31, 2021 | -1,255.70% |
| Sep 30, 2021 | -696.03% |
| Jun 30, 2021 | -357.70% |